From: Ceramides: a potential therapeutic target in pulmonary emphysema
Sphingolipid | Control (n=5) | Control + Sph (n=9) | Control + ZA (n=9) | Control + Des (n=10) | Elastase (n=5) | Elastase + Sph (n=9) | Elastase + ZA (n=9) | Elastase + Des (n=10) |
---|---|---|---|---|---|---|---|---|
Ceramide 16:0 | 23.39 ± 2.92 | 25.55 ± 1.23 | 26.07 ± 2.85 | 32.70 ± 3.12 * | 48.38 ± 4.46 * | 53.07 ± 12.34 *$ | 44.47 ± 11.93 *$ | 63.15 ± 13.15 *#$ |
Ceramide 18:0 | 2.61 ± 0.54 | 2.74 ± 0.30 | 2.83 ± 0.20 | 4.01 ± 0.70 | 4.88 ± 0.60 * | 5.66 ± 1.62 *$ | 4.43 ± 0.97 *$ | 7.45 ± 1.32 *#$ |
Ceramide 20:0 | 1.30 ± 0.34 | 1.24 ± 0.12 | 1.32 ± 0.14 | 1.97 ± 0.27 | 2.56 ± 0.37 * | 2.86 ± 0.78 *$ | 2.44 ± 0.37 *$ | 4.07 ± 0.82 *#$ |
Ceramide 22:0 | 7.95 ± 2.41 | 7.37 ± 0.70 | 9.75 ± 1.29 | 14.17 ± 1.89 * | 20.01 ± 4.39 * | 20.43 ± 5.74 *$ | 19.80 ± 4.73 *$ | 33.90 ± 7.71 *#$ |
Ceramide 24:0 | 33.63 ± 13.22 | 25.92 ± 2.66 | 42.31 ± 6.19 | 56.01 ± 6.39 * | 86.39 ± 22.72 * | 71.40 ± 16.60 *$ | 84.40 ± 16.74 *$ | 145.10 ± 41.79 *#$ |
Ceramide 24:1 | 19.09 ± 6.27 | 17.97 ± 0.90 | 22.81 ± 4.10 | 33.25 ± 4.01 * | 68.45 ± 19.42 * | 64.66 ± 16.75 *$ | 70.20 ± 16.85 *$ | 113.70 ± 26.87 *#$ |
Dihydro Ceramide 18:0 | 0.32 ± 0.07 | 0.38 ± 0.23 | 0.39 ± 0.30 | 0.42 ± 0.08 | 0.88 ± 0.21 * | 1.02 ± 0.35 *$ | 0.86 ± 0.20 *$ | 1.76 ± 0.24 *#$ |
Dihydro Ceramide 24:0 | 1.57 ± 0.67 | 1.67 ± 0.75 | 2.02 ± 1.11 | 2.32 ± 1.78 | 6.54 ± 1.78 * | 6.28 ± 2.49 *$ | 6.29 ± 1.52 *$ | 13.11 ± 5.03 *#$ |